Since 2002, Illumina has been providing high-quality DNA analysis services to the scientific community, including many of the top researchers from world-renowned institutions. This wealth of experience is now available to you through the CLIA-certified, CAP-accredited Illumina Clinical Services Laboratory.
CLIA stands for Clinical Laboratory Improvement Amendments. Essentially, CLIA is an important laboratory certification by the Centers for Medicare & Medicaid Services (CMS) for companies performing diagnostic testing. In total, CLIA covers approximately 200,000 laboratory entities. The objective of the CLIA program is to ensure quality laboratory testing.
To read more about CLIA, visit the Centers for Medicare and Medicaid Services.
The goal of the College of American Pathologists (CAP) laboratory accreditation program is to advance the quality of pathology and laboratory services through education, standard setting, and ensuring that laboratories meet or exceeds regulatory requirements. An accredited laboratory is one that is inspected by a not-for-profit accrediting organization that has been approved by the CMS.
The Illumina Clinical Services Laboratory currently offers physician-ordered genome sequencing services. The laboratory is staffed with certified Clinical Laboratory Scientists and uses the latest Illumina technology. In 2009, the laboratory was the first to generate a complete human genome sequence in a clinical laboratory setting.